New
HealthMore in Health→
FDA clears first approved treatment for chronic hepatitis D
The FDA has approved Hepcludex for adults with chronic hepatitis delta virus infection, marking the first U.S.-approved therapy for the disease.
Key Takeaways
- Hepcludex is the first FDA-approved therapy for chronic HDV.
- The drug was approved under the Accelerated Approval pathway.
DE
DT Editorial Team··via medicalxpress.com